丹参多酚酸盐联合艾司洛尔在老年冠心病心绞痛患者中的应用效果

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (578 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the application effect of Salvianolate combined with Esmolol in elderly patients with coronary heart disease and angina pectoris. Methods A total of 98 elderly patients with coronary heart disease and angina pectoris admitted to the Department of Emergency, Liaocheng Hospital of Traditional Chinese Medicine from September 2019 to September 2021 were selected as the study subjects. They were divided into observation group and control group by random number table method, with 49 cases in each group. Control group was treated with Esmolol,and observation group was treated with Salvianolate on the basis of control group. The efficacy, cardiac function, hemodynamics, oxidative stress index and medication safety of the two groups were compared before and after treatment.Results The total effective rate of observation group was higher than that of control group, the difference was statistically significant (P＜0.05). Before treatment, there were no statistically significant differences in left ventricular ejection fraction (LVEF), left ventricular end diastolic diameter (LVEDD) and left ventricular end systolic diameter (LVESD) between the two groups (P＞0.05). After treatment, the LVEF of the two groups were higher than those before treatment,LVEDD and LVESD were lower than those before treatment, LVEF of observation group was higher than that of the control group, LVEDD and LVESD were lower than those of the control group, the differences were statistically significant (P＜0.05). After treatment, fibrinogen, high whole blood viscosity, low whole blood viscosity and plasma viscosity in the two groups were lower than those before treatment, and fibrinogen, high whole blood viscosity, low whole blood viscosity and plasma viscosity in observation group were lower than those in control group, the differences were statistically significant (P＜0.05). After treatment, malondialdehyde (MDA) in both groups were lower than those before treatment,superoxide dismutase (SOD) were higher than those before treatment, and the MDA level in observation group was lower than that in control group, SOD level was higher than that in control group, the differences were statistically significant(P＜0.05). There was no statistically significant difference in the total incidence of adverse reactions between the two groups (P＞0.05). Conclusion Salvianolate combined with Esmolol in the treatment of angina pectoris in elderly patients with coronary heart disease can improve cardiac function, improve hemodynamics, reduce oxidative stress level, with significant efficacy and good safety, high application value.

Key words： Cardiac function Hemodynamics Oxidative stress Salvianolate Esmolol Coronary heart disease angina pectoris in the elderly

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MU Shaoning
	WEN Mingxin
	WU Chunyan

Cite this article:

MU Shaoning,WEN Mingxin,WU Chunyan. Application effect of Salvianolate combined with Esmolol in elderly patients with coronary heart disease and angina pectoris[J]. 中国当代医药, 2022, 29(15): 55-58.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I15/55

[1]	吴迪，张庆军.中国冠心病诊疗现状和进展[J].中国研究型医院，2020，7（1）：71-75,192-197.
[2]	朱亚红，冯红霞.冠心病稳定型心绞痛患者生活质量现状及影响因素[J].中国卫生工程学，2020，19（2）：223-225.
[3]	李洪峥，王阶，何浩强，等.基于中医思维的冠心病心绞痛病证结合诊疗知识模型构建[J].中医杂志，2019，60（15）：1288-1293.
[4]	于长生，宫丽鸿，赵殿臣.中西医结合治疗冠心病患者临床疗效观察[J].辽宁中医药大学学报，2019，28（5）：98-101.
[5]	石振清.冠心病心绞痛诊断与鉴别诊断的程序[J].宁夏医学杂志，1991（5）：316-318，321.
[6]	孙丽芳.艾司洛尔对冠心病心肌缺血患者心率、血压等指标的影响分析[J].医学理论与实践，2020，33（5）：731-732.
[7]	李春梅.艾司洛尔在冠心病心肌缺血治疗中的应用效果[J].世界最新医学信息文摘，2020，20（4）：147-149.
[8]	崔大伟，孟帅，金泽宁.丹参多酚酸盐在冠心病心绞痛患者中的应用效果[J].中国当代医药，2020，27（28）：47-50，54.
[9]	闫伟.丹参多酚酸盐治疗冠心病不稳定型心绞痛的效果观察[J].中西医结合心血管病杂志，2020，8（4）：86，93.
[10]	张炳芳.美托洛尔和丹参多酚酸盐治疗冠心病心绞痛的效果研究[J].当代医药论丛，2019，17（12）：189-190.
[11]	张志亮.丹参多酚酸盐治疗冠心病的疗效观察[J].中国合理用药探索，2019，16（2）：105-108.
[12]	吴佳健.丹参多酚酸盐治疗冠心病的临床疗效及安全性分析[J].基层医学论坛，2019，23（22）：3158-3159.
[13]	郑静，李军.注射用丹参多酚酸治疗冠心病心绞痛的临床研究进展[J].药物评价研究，2020，43（9）：1919-1922.
[14]	王欢，魏书艳，杨凡，等.丹参多酚酸对老年脑卒中患者血清半乳糖凝集素-3、超敏C 反应蛋白水平的影响[J].中国现代医学杂志，2019，29（17）：75-78.
[15]	康晓军，王西辉，邱军杰，等.128 层螺旋CT 评价丹参多酚酸盐联合阿司匹林对冠心病心绞痛的患者左心功能的影响[J].中国CT 和MRI 杂志，2019，17（11）：58-60，80.
[16]	关敬树，周云，缪志静，等.丹参多酚酸盐对冠心病患者内皮功能及氧化应激状态的影响[J].中国药业，2019，28（24）：75-77.
[17]	李德坤，苏志刚，万梅绪，等.注射用丹参多酚酸药理作用及临床应用研究进展[J].药物评价研究，2019，42（2）：353-361.
[18]	尚雨露.注射用丹参多酚酸联合丁苯酞注射液治疗脑梗死的效果及对神经功能恢复、氧化应激指标的影响[J].哈尔滨医药，2019，39（6）：542-543.
[19]	刘会会，尹佳，强明敏，等.丹参多酚酸盐药理作用研究进展[J].中国当代医药，2021，28（22）：32-36，41.
[20]	幸敬芬，崔海明，刘浩琪，等.丹参多酚酸盐对非ST 段抬高型急性冠状动脉综合征患者PCI 术后的疗效及安全性研究[J].疑难病杂志，2021，20（1）：13-16，21.